Baxter’s BioScience business has manufacturing expertise in plasma fractionation technology.
Baxter’s plasma fractionation method is increasingly more efficient and helps improve product yields from plasma donations. Plasma contains thousands of different therapeutic proteins, and fractionation concentrates the necessary proteins. The company’s experience in plasma fractionation has resulted in the development of reliable and innovative therapies that ensure the treatment of various chronic conditions.
Ready-to-use 10% sterile, liquid preparation
Read More [+]
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
Read More [+]
A comprehensive portfolio of Ig products for all treatment settings - hospital, outpatient, clinic, and home.
Please consult your local approved product labeling for prescribing information. Please note that not all products are licensed in all countries.